. iPS lines generated in this study. Figure 2 ) Donor blood cells collection and isolation. Frozen normal peripheral blood (PB) CD34+ cells (PB033F-1, Lot A1818) were obtained from Allcells. Briefly, peripheral blood was isolated from a 49 year-old male donor who had undergone apheresis (Cobe Spectra Apheresis machine). CD34+ cells were purified using Miltenyi's Indirect CD34+ Microbeads and AutoMACS Pro. Typically, 350ml of whole blood yield 1x10 9 PB mononuclear cells from which 1 million CD34+ cells can be isolated. For the isolation of mononuclear cells, peripheral blood was collected by venipuncture from a healthy 28-year old male donor (GH Dad61). Ficoll-hypaque density-gradient centrifugation was used to separate the mononuclear cells with the red blood cells and granulocytes. In another experiment, whole blood was purchased from Zen-bio, Inc. (Research Triangle Park, NC) . Whole blood samples were collected from a healthy 30-year old female donor (34), 31-year old female donor (50) and 49-year old male donor (76) by venipuncture in heparinized collection tubes and tested for human pathogens. The samples were shipped at 4 o C and processed 3 days later at iPierian, Inc. where PBMCs were isolated using a Ficoll-hypaque density-gradient centrifugation. Remaining red blood cells were lysed using red blood cell lysis buffer (Sigma-Aldrich). Isolations of samples from human subjects were performed according to the institutional guidelines and regulations.
Immunohistochemistry staining. Cells were fixed in 4% paraformaldehyde for 30 min, permeabilized with 0.2% Triton X-100 for 30 min, and blocked in 3% BSA in PBS for 2 hours. Cells were incubated with primary antibody overnight at 4 o C, washed, and incubated with Alexa Fluor (Invitrogen) secondary antibody for 2 hours. SSEA4, TRA-1-60 and TRA-1-81 antibodies were obtained from Millipore. OCT3/4 and NANOG antibodies were obtained from Abcam. Alkaline phosphatase staining was done according to the manufacturer's recommendations (Millipore).
qRT-PCR. RNA was isolated using an RNeasy kit (Qiagen) according to manufacturer's protocol. First-strand cDNA was primed via oligo-dT primers and RT-PCR was performed with primer sets described previously (Park et al. 2008a ). Quantitative RT-PCR was performed using Brilliant SYBR green (Stratagene).
Global gene expression. Gene expression profiling was carried out using Human Genome HGU133 plus 2.0 Affymetrix GeneChip arrays. In brief, total RNA was extracted from cells with the RNAeasy kit including DNase digestion (Qiagen). Biotinlabeled cDNA was obtained from 1 microgram of total RNA with the GeneChip OneCycle labeling kit (Affymetrix). One-and-a-half micrograms of cDNA were fragmented and hybridized to Affymetrix HGU133 plus 2.0 GeneChip arrays according to the manufacturer's instructions. DNA chips were washed, stained and scanned using an Affymetrix Fluidics device and a GCS3000 scanner, and the images obtained were analysed using GCOS software. The experiment was performed in duplicate for the dH1F, PB_CD34+, PBMC, hESC and all the iPS cells. Data normalization was calculated with the robust multichip average (RMA) algorithm (Rafael et al. 2003) implemented in BioConductor (http://www.bioconductor.org/). The cluster analysis was performed and scatter plots were generated in R packages (http://www.r-project.org/). The array data have been deposited in the GEO database under the accession number GSE22167.
Bisulfite genomic sequencing. Bisulfite treatment of genomic DNA (gDNA) was carried out using a CpGenome DNA Modification Kit (Chemicon) according to the manufacturer's protocol. Briefly, converted gDNA was amplified by PCR NANOG primer set 3, as reported previously (Freberg et al. 2007) . PCR products were gel-purified and cloned into bacteria using the TOPO TA cloning kit (Invitrogen). Bisulfite conversion efficiency of non-CpG cytosines ranged from 80% to 99% for all individual clones for each sample.
DNA fingerprinting and karyotyping. Analysis of the DNA fingerprinting was performed on parental PB CD34+ cells, PB MNCs and their derivative iPS cell lines. DNA was extracted using DNeasy Blood and Tissue kit (Qiagen) according to the manufacturer's protocol and sent to Cell Line Genetics (Wisconsin, USA) for analysis. For karyotyping of the chromosome, live iPS lines were sent to Cell Line Genetics (Wisconsin, USA) for analysis.
Embryoid body formation.
To form embryoid bodies, confluent undifferentiated iPS cells were mechanically scraped into strips and transferred to 6-well, low attachment plates in differentiation medium consisting of knockout DMEM (Invitrogen) supplemented with 20% fetal bovine serum (StemCell Technologies), 0.1 mM nonessential amino acids (Invitrogen), 1 mM L-glutamine (Invitrogen), 50ug ml -1 ascorbic acid (Sigma) and 2mg ml -1 human holo-transferrin (Sigma) and 0.1 mM β-mercaptoethanol (Sigma).
Hematopoietic colony-forming assays. Human iPS lines were differentiated for 14 days as embryoid bodies in culture media described above supplemented with SCF (300 ng ml -1 ), Flt-3 ligand (300 ng ml -1 ), IL-3 (10 ng ml -1 ), IL-6 (10 ng ml -1 ), G-CSF (50 ng ml -1 ) and BMP4 (50 ng ml -1 ). Embryoid bodies were dissociated and plated into methylcellulose colony-forming assay media containing SCF, GM-CSF, IL-3 and Epo (H4434, Stem Cell Technologies) at a density of 25,000 cells ml -1 .
Assay for teratoma formation. For teratoma formation, PB34 and PBMC (GH) iPS cells were suspended in a mixture of DMEM, Matrigel and collagen (ratio of 2:1:1) and injected intramuscularly into immune-compromised Rag2
-/-γC -/-mice. Xenografted masses formed within 4 to 7 weeks, and paraffin sections were stained with haematoxylin and eosin for all histological determinations.
Flow cytometry. Peripheral blood cells were stained with a panel of antibodies at the manufacturer's suggested dilution in PBS/2% serum on ice for 20 minutes. This panel included CD3 (UCHT1), CD4 (RPA-T4), CD11b (ICRF44), CD15 (HI98), CD19 (HIB19), CD34 (563), CD38 (HB7), and CD45 (HI30) from BD Bioscience, and CD14 (TUK4) from Caltag. Propidium iodide was used for live/dead discrimination. Flow cytometry was performed on a 5-laser LSR-II cell analyzer (BD Bioscience) or Accuri C6 Flow Cytometer (Accurisystems), and data were analyzed using FlowJo software (Treestar, Inc.). Southern Blot analysis. DNA was isolated from iPS and control cell lines using DNeasy Blood and Tissue kit (Qiagen) per the manufacturer's protocol. 5-10 micrograms of DNA were digested with the appropriate restriction enzymes (New England Biolabs), sizeseparated in 8% agarose gels and transferred to nylon membranes (Bio-Rad) as previously described (Szczepanski et al. 2001) . IgH gene rearrangements were detected with IgH J H 6 probe (772bp; forward 5'-GTGACCTCTCTCCGCTTCAC-3', reverse 5'-TATTTCACGATTCGCTGCTG-3') in HindIII digests. TCRδ gene rearrangements were studied by the use of 3' J δ 3 probe (993bp; forward 5'-AATTTGAGTCCTGGCACTGG-3', reverse 5'-CCATTGTTTGGCATCTTGGT-3') in Nco1 digests. TCRβ gene rearrangements were detected with 3' J β2 7 probe (883bp; forward 5'-TCAGAGTCCGGAAAGCTGAG-3', reverse 5'-TAGCTGAGCCCCATTACACC-3') in HindIII digests.
